These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21530342)

  • 21. Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer.
    Meher RK; Pragyandipta P; Reddy PK; Pedaparti R; Kantevari S; Naik PK
    J Biomol Struct Dyn; 2022; 40(23):13136-13153. PubMed ID: 34583618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXI-benzo-84 reversibly binds to tubulin at colchicine site and induces apoptosis in cancer cells.
    Rai A; Gupta TK; Kini S; Kunwar A; Surolia A; Panda D
    Biochem Pharmacol; 2013 Aug; 86(3):378-91. PubMed ID: 23747346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidation of the Tubulin-targeted Mechanism of Action of 9-(3-pyridyl) Noscapine.
    Pradhan S; Mahaddalkar T; Choudhary S; Manhcukonda N; Nagireddy PR; Kantevari S; Lopus M
    Curr Top Med Chem; 2017; 17(22):2569-2574. PubMed ID: 28056737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model.
    Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK
    Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new antiproliferative noscapine analogue: chemical synthesis and biological evaluation.
    Ghaly PE; Abou El-Magd RM; Churchill CD; Tuszynski JA; West FG
    Oncotarget; 2016 Jun; 7(26):40518-40530. PubMed ID: 27777381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical characterization and molecular dynamic simulation of β-sitosterol as a tubulin-binding anticancer agent.
    Mahaddalkar T; Suri C; Naik PK; Lopus M
    Eur J Pharmacol; 2015 Aug; 760():154-62. PubMed ID: 25912799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrostatic contributions to colchicine binding within tubulin isotypes.
    Huzil JT; Barakat K; Tuszynski JA
    Electromagn Biol Med; 2009; 28(4):355-64. PubMed ID: 20017626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noscapine and its Analogs as Chemotherapeutic Agent: Current updates.
    Tomar V; Kukreti S; Prakash S; Madan J; Chandra R
    Curr Top Med Chem; 2017; 17(2):174-188. PubMed ID: 27237331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q; Wang Y; Wang R; Lai W; Tang L; Tao Y; Liu Y; Zhang R; Huang L; Xiang H; Zeng S; Gou L; Chen H; Yao Y; Yang J
    Eur J Med Chem; 2018 Aug; 156():162-179. PubMed ID: 30006162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Tubulin-colchicine Site for Cancer Therapy: Inhibitors, Antibody- Drug Conjugates and Degradation Agents.
    Duan Y; Liu W; Tian L; Mao Y; Song C
    Curr Top Med Chem; 2019; 19(15):1289-1304. PubMed ID: 31210108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine.
    Cheriyamundath S; Mahaddalkar T; Reddy Nagireddy PK; Sridhar B; Kantevari S; Lopus M
    Pharmacol Rep; 2019 Feb; 71(1):48-53. PubMed ID: 30465924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of docetaxel and newly synthesized 9-Br-trimethoxybenzyl-noscapine improve tubulin binding and enhances antitumor activity in breast cancer cells.
    Dash SG; Kantevari S; Guru SK; Naik PK
    Comput Biol Med; 2021 Dec; 139():104996. PubMed ID: 34753081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational design of novel anti-microtubule agent (9-azido-noscapine) from quantitative structure activity relationship (QSAR) evaluation of noscapinoids.
    Santoshi S; Naik PK; Joshi HC
    J Biomol Screen; 2011 Oct; 16(9):1047-58. PubMed ID: 21972248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery.
    Wang Y; Zhang H; Gigant B; Yu Y; Wu Y; Chen X; Lai Q; Yang Z; Chen Q; Yang J
    FEBS J; 2016 Jan; 283(1):102-11. PubMed ID: 26462166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The interaction of the B-ring of colchicine with alpha-tubulin: a novel footprinting approach.
    Chaudhuri AR; Seetharamalu P; Schwarz PM; Hausheer FH; Ludueña RF
    J Mol Biol; 2000 Nov; 303(5):679-92. PubMed ID: 11061968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin.
    Sun K; Sun Z; Zhao F; Shan G; Meng Q
    Future Med Chem; 2021 May; 13(9):839-858. PubMed ID: 33821673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrimination of ligands with different flexibilities resulting from the plasticity of the binding site in tubulin.
    Chakraborti S; Chakravarty D; Gupta S; Chatterji BP; Dhar G; Poddar A; Panda D; Chakrabarti P; Ghosh Dastidar S; Bhattacharyya B
    Biochemistry; 2012 Sep; 51(36):7138-48. PubMed ID: 22891709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain.
    Zhao W; He L; Xiang TL; Tang YJ
    Eur J Med Chem; 2019 May; 170():73-86. PubMed ID: 30878833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brominated derivatives of noscapine are potent microtubule-interfering agents that perturb mitosis and inhibit cell proliferation.
    Zhou J; Gupta K; Aggarwal S; Aneja R; Chandra R; Panda D; Joshi HC
    Mol Pharmacol; 2003 Apr; 63(4):799-807. PubMed ID: 12644580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.